The University of Chicago Header Logo

Connection

Hiroyuki Abe to Aged

Back to Details
This is a "connection" page, showing publications Hiroyuki Abe has written about Aged.
Hiroyuki Abe
Connection Strength
0.725
Aged
  1. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage. PLoS One. 2021; 16(9):e0256440.
    View in: PubMed
    Score: 0.051
  2. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation. AJR Am J Roentgenol. 2020 08; 215(2):511-518.
    View in: PubMed
    Score: 0.047
  3. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions. AJR Am J Roentgenol. 2018 10; 211(4):933-939.
    View in: PubMed
    Score: 0.041
  4. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH). J Magn Reson Imaging. 2017 12; 46(6):1738-1747.
    View in: PubMed
    Score: 0.038
  5. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment. AJR Am J Roentgenol. 2016 Nov; 207(5):1159-1166.
    View in: PubMed
    Score: 0.036
  6. MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes. J Magn Reson Imaging. 2015 Oct; 42(4):920-4.
    View in: PubMed
    Score: 0.033
  7. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer. J Magn Reson Imaging. 2015 Sep; 42(3):771-8.
    View in: PubMed
    Score: 0.032
  8. Decision making for breast lesions initially detected at contrast-enhanced breast MRI. AJR Am J Roentgenol. 2013 Dec; 201(6):1376-85.
    View in: PubMed
    Score: 0.030
  9. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound. Acad Radiol. 2013 Nov; 20(11):1399-404.
    View in: PubMed
    Score: 0.030
  10. Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases. AJR Am J Roentgenol. 2013 Nov; 201(5):1155-63.
    View in: PubMed
    Score: 0.030
  11. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol. 2013 Mar; 200(3):696-702.
    View in: PubMed
    Score: 0.028
  12. MR-directed ("Second-Look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol. 2010 Feb; 194(2):370-7.
    View in: PubMed
    Score: 0.023
  13. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients. Radiology. 2009 Jan; 250(1):41-9.
    View in: PubMed
    Score: 0.021
  14. K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy. J Appl Clin Med Phys. 2026 Jan; 27(1):e70439.
    View in: PubMed
    Score: 0.017
  15. Postmortem computed tomography assessment of intracardiac and intravascular blood clots and gravitational sedimentation: clinical and laboratory associations in 114 in-hospital deaths. Jpn J Radiol. 2025 Sep; 43(9):1465-1478.
    View in: PubMed
    Score: 0.017
  16. Effect of temporal subtraction images on radiologists' detection of lung cancer on CT: results of the observer performance study with use of film computed tomography images. Acad Radiol. 2004 Dec; 11(12):1337-43.
    View in: PubMed
    Score: 0.016
  17. Artificial neural networks (ANNs) for differential diagnosis of interstitial lung disease: results of a simulation test with actual clinical cases. Acad Radiol. 2004 Jan; 11(1):29-37.
    View in: PubMed
    Score: 0.015
  18. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer. Magn Reson Imaging. 2023 12; 104:9-15.
    View in: PubMed
    Score: 0.015
  19. Elucidation of the mechanism of amyloid A and transthyretin formation using mass spectrometry-based absolute quantification. Virchows Arch. 2024 Nov; 485(5):943-946.
    View in: PubMed
    Score: 0.015
  20. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
    View in: PubMed
    Score: 0.013
  21. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer. 2021 Sep; 28(5):1141-1153.
    View in: PubMed
    Score: 0.012
  22. Relationship between detection of hepatitis B virus in saliva and periodontal disease in hepatitis B virus carriers in Japan. J Infect Chemother. 2021 Mar; 27(3):492-496.
    View in: PubMed
    Score: 0.012
  23. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology. 2021 Feb; 78(3):381-391.
    View in: PubMed
    Score: 0.012
  24. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling. Cancer Imaging. 2019 Jul 15; 19(1):48.
    View in: PubMed
    Score: 0.011
  25. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial. J Magn Reson Imaging. 2019 06; 49(6):1617-1628.
    View in: PubMed
    Score: 0.010
  26. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density. Acad Radiol. 2019 07; 26(7):e141-e149.
    View in: PubMed
    Score: 0.010
  27. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI. Eur Radiol. 2019 Apr; 29(4):1778-1786.
    View in: PubMed
    Score: 0.010
  28. Lymph node wire localization post-chemotherapy: Towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients. Clin Imaging. 2018 Mar - Apr; 48:69-73.
    View in: PubMed
    Score: 0.010
  29. Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies. Invest Radiol. 2016 07; 51(7):454-61.
    View in: PubMed
    Score: 0.009
  30. Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis. Acad Radiol. 2016 09; 23(9):1137-44.
    View in: PubMed
    Score: 0.009
  31. Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer. Breast Cancer. 2015 Sep; 22(5):496-502.
    View in: PubMed
    Score: 0.008
  32. A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):615-22.
    View in: PubMed
    Score: 0.007
  33. Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Acad Radiol. 2011 Dec; 18(12):1467-74.
    View in: PubMed
    Score: 0.006
  34. Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol. 2010 Jun; 194(6):1674-9.
    View in: PubMed
    Score: 0.006
  35. Potential usefulness of similar images in the differential diagnosis of clustered microcalcifications on mammograms. Radiology. 2009 Dec; 253(3):625-31.
    View in: PubMed
    Score: 0.006
  36. DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7):3102-9.
    View in: PubMed
    Score: 0.005
  37. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med. 2008 Apr; 59(4):747-54.
    View in: PubMed
    Score: 0.005
  38. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology. 2007 Dec; 245(3):684-91.
    View in: PubMed
    Score: 0.005
  39. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. Magn Reson Imaging. 2007 Jun; 25(5):593-603.
    View in: PubMed
    Score: 0.005
  40. High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. AJR Am J Roentgenol. 2006 Jan; 186(1):30-7.
    View in: PubMed
    Score: 0.004
  41. Computer-aided detection of peripheral lung cancers missed at CT: ROC analyses without and with localization. Radiology. 2005 Nov; 237(2):684-90.
    View in: PubMed
    Score: 0.004
  42. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology. 2004 Dec; 233(3):793-8.
    View in: PubMed
    Score: 0.004
  43. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol. 2003 Sep; 10(9):1013-20.
    View in: PubMed
    Score: 0.004
  44. Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology. 2002 Dec; 225(3):673-83.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.